The study unprecendently provided evidence about the molecular understanding of a dedifferentiation phenotype of glioblastoma-a highly aggressive brain tumour with 12-15 months of patient survival after diagnosis. Further, the efficacies of survivin targeting molecules SurR9-C84A and a natural non-toxic protein bovine lactoferrin as a safe bio-drug to target glioblastoma were evaluated
Field of Research
111201 Cancer Cell Biology 111204 Cancer Therapy (excl Chemotherapy and Radiation Therapy)
Socio Economic Objective
920102 Cancer and Related Disorders
Description of original
xv, 442 pages : illustrations, graphs, tables, some coloured
Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact firstname.lastname@example.org.